Skin Primary Irritation Test in Humans

Dermapro0 个研究点目标入组 30 人开始时间: 待定最近更新: 2019年6月17日

试验速览

暂无简介。

•?Healthy females or males aged 20 to 60 years
•?Subjects who signed the informed consent; the purpose and the protocol of the study are explained to subjects.
•?Subjects who are willing to cooperate with the requirements of the study during the test period and contact investigator immediately if they experience any adverse reaction.
•?Subjects should be cooperative and available for follow-up during the study period.

•?Women who are self-reported pregnant, nursing or planning a pregnancy
•?Subjects with a history of any dermatological disease or condition, including but not limited to active atopic dermatitis, psoriasis, eczema, active seasonal allergies within the past a months
•?Subjects with abnormal skin pigmentation at the test sites which might interfere with subsequent evaluations of dermal responsiveness
•?Subjects taking medications which might interfere with the test results, including anti-inflammatory, antihistamines or immunosuppressive drugs
•?Subjects who have applied any type of topical anti-inflammatory medication to the test sites within two weeks prior to enrollment
•?Subjects with any other skin condition that would interfere with the conduct of the study
•?Subjects with a history of immune deficiency or auto-immune disease
•?Subjects who are currently receiving allergy injections, have received allergy injections within one week prior to enrollment, or expect to begin receiving allergy injections during the study
•?Subjects who are currently under treatment for chronic diseases (asthma and diabetes etc.)
•?Current enrollment in any other research study or participation in a patch test study within 30 days prior to the start of this study
•?Subjects who are known tape/adhesive reactors

发起方